T. Rowe Price Associates »

Corbus Pharmaceuticals Hldgs shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7M 326k 20.63
2024-06-30 $14M 302k 45.26
2024-03-31 $7.6M 193k 39.24

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Octagon Capital Advisors
OrbiMed Advisors
BlackRock
BlackRock
Ikarian Capital
Tang Capital Management
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Morgan Stanley
Geode Capital Management
Sio Capital Management
Schonfeld Strategic Advisors

View all funds holding Corbus Pharmaceuticals Hldgs